Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.60 |
| ▸ | NCF1 | P14598 | 5/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | GALR3 | O60755 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6494917 | 0.85 | CYP1A2 (0.60) | CYP1A2NCF1CYP2C19KDM4ESMN1; SMN2 | |
| SCHEMBL1366357 | 0.82 | CYP1A2 (0.62) | CYP1A2NCF1CYP2C19KDM4ESMN1; SMN2 | |
| SCHEMBL8232676 | 0.82 | CYP1A2 (0.62) | CYP1A2NCF1CYP2C19KDM4ESMN1; SMN2 | |
| SCHEMBL4870967 | 0.82 | CYP1A2 (0.53) | CYP1A2NCF1CYP2C19KDM4ESMN1; SMN2 | |
| SCHEMBL994597 | 0.81 | CYP1A2 (0.60) | CYP1A2NCF1CYP2C19KDM4ESMN1; SMN2 | |
| SCHEMBL3921968 | 0.81 | CYP1A2 (0.60) | CYP1A2NCF1CYP2C19KDM4ESMN1; SMN2 | |
| SCHEMBL3964916 | 0.81 | CYP1A2 (0.60) | CYP1A2NCF1CYP2C19KDM4ESMN1; SMN2 | |
| SCHEMBL265139 | 0.81 | NCF1 (0.61) | CYP1A2NCF1CYP2C19KDM4ESMN1; SMN2 | |
| SCHEMBL6494921 | 0.81 | CYP1A2 (0.60) | CYP1A2NCF1CYP2C19KDM4ESMN1; SMN2 | |
| SCHEMBL5898542 | 0.81 | CYP1A2 (0.60) | CYP1A2NCF1CYP2C19KDM4ESMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1322627-A1 | CYCLIC SULFONYL COMPOUNDS AS INHIBITORS OF METALLOPROTEASES | Bristol-Myers Squibb Pharma Company (US) | 2003-07-02 | — | — | EP | disclosed |
| WO-2002048116-A2 | INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2002-06-20 | — | — | WO | disclosed |
| WO-2002028846-A1 | CYCLIC SULFONYL COMPOUNDS AS INHIBITORS OF METALLOPROTEASES | DUPONT PHARMACEUTICALS COMPANY (US) | 2002-04-11 | — | — | WO | disclosed |